Author
Listed:
- Adrian J. Thrasher
(Molecular Immunology Unit, Institute of Child Health, University College London
Great Ormond Street Hospital for Children NHS Trust)
- H. Bobby Gaspar
(Molecular Immunology Unit, Institute of Child Health, University College London
Great Ormond Street Hospital for Children NHS Trust)
- Christopher Baum
(Hannover Medical School
Cincinnati Children's Hospital Medical Center)
- Ute Modlich
(Hannover Medical School)
- Axel Schambach
(Hannover Medical School)
- Fabio Candotti
(Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health)
- Makoto Otsu
(Center for Experimental Medicine, University of Tokyo)
- Brian Sorrentino
(St Jude Children's Research Hospital)
- Linda Scobie
(Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow)
- Ewan Cameron
(Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow)
- Karen Blyth
(Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow)
- Jim Neil
(Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow)
- Salima Hacein-Bey Abina
(INSERM Unit 768, Hôpital Necker, Assistance Publique–Hôpitaux de Paris
Assistance Publique–Hôpitaux de Paris)
- Marina Cavazzana-Calvo
(INSERM Unit 768, Hôpital Necker, Assistance Publique–Hôpitaux de Paris
Assistance Publique–Hôpitaux de Paris
Faculté de Médecine, Université René Descartes)
- Alain Fischer
(INSERM Unit 768, Hôpital Necker, Assistance Publique–Hôpitaux de Paris
Faculté de Médecine, Université René Descartes
Unité d'Immuno-Hématologie Pédiatrique, Assistance Publique–Hôpitaux de Paris)
Abstract
Arising from: Woods, N.-B., Bottero, V., Schmidt, M., von Kalle, C. & Verma, I. M. Nature 440, 1123 (2006); see also communication from Pike-Overzet et al. ; Woods et al. reply Gene therapy has been remarkably effective for the immunological reconstitution of patients with severe combined immune deficiency1,2,3, but the occurrence of leukaemia in a few patients has stimulated debate about the safety of the procedure and the mechanisms of leukaemogenesis4. Woods et al.5 forced high expression of the corrective therapeutic gene IL2RG, which encodes the γ-chain of the interleukin-2 receptor, in a mouse model of the disease and found that tumours appeared in a proportion of cases. Here we show that transgenic IL2RG does not necessarily have potent intrinsic oncogenic properties, and argue that the interpretation of this observation with respect to human trials is overstated.
Suggested Citation
Adrian J. Thrasher & H. Bobby Gaspar & Christopher Baum & Ute Modlich & Axel Schambach & Fabio Candotti & Makoto Otsu & Brian Sorrentino & Linda Scobie & Ewan Cameron & Karen Blyth & Jim Neil & Salima, 2006.
"X-SCID transgene leukaemogenicity,"
Nature, Nature, vol. 443(7109), pages 5-6, September.
Handle:
RePEc:nat:nature:v:443:y:2006:i:7109:d:10.1038_nature05219
DOI: 10.1038/nature05219
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:443:y:2006:i:7109:d:10.1038_nature05219. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.